A Research Study for Latina Women With Breast Cancer

Acceptability of My Guide: Usefulness

To assess acceptability, all participants are asked to complete an exit interview on My Guide. This interview assesses usefulness, satisfaction, learnability and usability of the application. This exit interview was synthesized from validated measures assessing eHealth intervention acceptability, and was adapted for our study to better fit our target population and our application design. Above average scores on the questionnaire are considered acceptable. The questionnaire is administered over the phone immediately following the 12 week intervention.

Time frame: T3 (immediately following 12 week intervention)

Acceptability of My Guide: Satisfaction

To assess acceptability, all participants are asked to complete an exit interview on My Guide. This interview assesses usefulness, satisfaction, learnability and usability of the application. This exit interview was synthesized from validated measures assessing eHealth intervention acceptability, and was adapted for our study to better fit our target population and our application design. Above average scores on the questionnaire are considered acceptable. The questionnaire is administered over the phone immediately following the 12 week intervention.

Time frame: T3 (immediately following 12 week intervention)

Acceptability of My Guide: Learnability

To assess acceptability, all participants are asked to complete an exit interview on My Guide. This interview assesses usefulness, satisfaction, learnability and usability of the application. This exit interview was synthesized from validated measures assessing eHealth intervention acceptability, and was adapted for our study to better fit our target population and our application design. Above average scores on the questionnaire are considered acceptable. The questionnaire is administered over the phone immediately following the 12 week intervention.

Time frame: T3 (immediately following 12 week intervention)

Acceptability of My Guide: Usability

To assess acceptability, all participants are asked to complete an exit interview on My Guide. This interview assesses usefulness, satisfaction, learnability and usability of the application. This exit interview was synthesized from validated measures assessing eHealth intervention acceptability, and was adapted for our study to better fit our target population and our application design. Above average scores on the questionnaire are considered acceptable. The questionnaire is administered over the phone immediately following the 12 week intervention.

Time frame: T3 (immediately following 12 week intervention)

Demand of My Guide: Recruitment Rate

We assess demand of the My Guide application through study recruitment. Based on previous psychosocial and behavioral studies in oncology, an 70% recruitment rate is considered an adequate level of demand.

Time frame: 12 weeks

Demand of My Guide: Retention Rate

Another way we assess demand of the My Guide application is through participant retention. Based on previous psychosocial and behavioral studies in oncology, an 70% retention rate is considered an adequate level of demand.

Time frame: 12 weeks

Participant use of My Guide: Number of Login's

We assess participant use of the My Guide application by examining the number of participant logins to the web-based application.

Time frame: 12 weeks

Participant use of My Guide: Duration of Usage

We assess participant use of the My Guide application by examining the duration participant time spent on the website. Based on previous psychosocial and behavioral studies in oncology, an average of 8 hours of use is considered an adequate level of engagement.

Time frame: 12 weeks

Participant use of My Guide: Content Accessed

We assess participant use of the My Guide application by examining the type of content accessed by participants on the website.

Time frame: 12 weeks

Change in Medication adherence will be assessed primarily with the Adherence to Refills and Medication Scale (ARMS).

The ARMS (Adherence to Refills and Medications Scale) survey is a previously validated patient-report measure of barriers to medication adherence and adherence-related behavior.

Time frame: T1 (prior to starting intervention), T2 (6 weeks into intervention), T3 (immediately following 12 week intervention)